Applicant, as named in the Orange Book

Tetraphase Pharms

Next listed expiry: Xerava on 19 Oct 2037. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xerava · 2 strengths eravacycline dihydrochloride	eravacycline dihydrochloride	211109	19 Oct 2037	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.